July 2015

Romidepsin Maintenance After Allogeneic Stem Cell Transplantation

Conditions:   Cutaneous T-cell Lymphoma;   T-Prolymphocytic Leukemia;   T-Large Granulocytic Leukemia;   T-Lymphoblastic Leukemia/Lymphoma;   Peripheral T-Cell Lymphoma
Interventions:   Drug: Romidepsin;   Drug: Busulfan;   Drug: Fludarabine;   Procedure: Stem Cell Transplant;   Drug: Thymoglobulin
Sponsors:   M.D. Anderson Cancer Center;   Celgene Corporation
Recruiting - verified January 2017

Effects of Inhibiting Early Inflammation in Kidney Transplant Patients

Condition:   Kidney Transplant
Interventions:   Biological: Infliximab;   Drug: Methylprednisolone;   Drug: Mycophenolate Mofetil;   Drug: Tacrolimus;   Biological: Thymoglobulin;   Drug: Acetaminophen;   Drug: Loratadine;   Biological: Placebo for Infliximab;   Drug: Prednisone;   Drug: Diphenhydramine
Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Clinical Trials in Organ Transplantation
Recruiting - verified September 2016